225 related articles for article (PubMed ID: 26852862)
21. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
[TBL] [Abstract][Full Text] [Related]
22. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
[TBL] [Abstract][Full Text] [Related]
23. Taurine Administration Mitigates Cisplatin Induced Acute Nephrotoxicity by Decreasing DNA Damage and Inflammation: An Immunocytochemical Study.
Tsunekawa M; Wang S; Kato T; Yamashita T; Ma N
Adv Exp Med Biol; 2017; 975 Pt 2():703-716. PubMed ID: 28849493
[TBL] [Abstract][Full Text] [Related]
24. Effect of metformin against cisplatin induced acute renal injury in rats: a biochemical and histoarchitectural evaluation.
Sahu BD; Kuncha M; Putcha UK; Sistla R
Exp Toxicol Pathol; 2013 Sep; 65(6):933-40. PubMed ID: 23395153
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats.
Uzunoglu S; Karagol H; Ozpuyan F; Cosar R; Cicin I; Yurutcaloglu V; Denizli B; Tanriverdi Ö; Sut N; Kocak Z
Med Oncol; 2011 Dec; 28 Suppl 1():S690-6. PubMed ID: 21140244
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
Yoshida T; Kumagai H; Kohsaka T; Ikegaya N
Nephron Exp Nephrol; 2014; 128(1-2):9-20. PubMed ID: 25403022
[TBL] [Abstract][Full Text] [Related]
27. Assessment of cisplatin-induced kidney injury using an integrated rodent platform.
Chen Y; Brott D; Luo W; Gangl E; Kamendi H; Barthlow H; Lengel D; Fikes J; Kinter L; Valentin JP; Bialecki R
Toxicol Appl Pharmacol; 2013 May; 268(3):352-61. PubMed ID: 23415679
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and toxicodynamics of cisplatin and its metabolites in rats: relationship between renal handling and nephrotoxicity of cisplatin.
Hanada K; Ninomiya K; Ogata H
J Pharm Pharmacol; 2000 Nov; 52(11):1345-53. PubMed ID: 11186242
[TBL] [Abstract][Full Text] [Related]
29. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
30. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity.
Sanchez-Gonzalez PD; Lopez-Hernandez FJ; Perez-Barriocanal F; Morales AI; Lopez-Novoa JM
Nephrol Dial Transplant; 2011 Nov; 26(11):3484-95. PubMed ID: 21602180
[TBL] [Abstract][Full Text] [Related]
31. Effect of L-histidinol on cisplatin nephrotoxicity in the rat.
Badary OA; Nagi MN; Al-Sawaf HA; Al-Harbi M; Al-Bekairi AM
Nephron; 1997; 77(4):435-9. PubMed ID: 9434066
[TBL] [Abstract][Full Text] [Related]
32. Involvement of indoxyl sulfate in renal and central nervous system toxicities during cisplatin-induced acute renal failure.
Iwata K; Watanabe H; Morisaki T; Matsuzaki T; Ohmura T; Hamada A; Saito H
Pharm Res; 2007 Apr; 24(4):662-71. PubMed ID: 17318420
[TBL] [Abstract][Full Text] [Related]
33. The dimethylthiourea-induced attenuation of cisplatin nephrotoxicity is associated with the augmented induction of heat shock proteins.
Tsuji T; Kato A; Yasuda H; Miyaji T; Luo J; Sakao Y; Ito H; Fujigaki Y; Hishida A
Toxicol Appl Pharmacol; 2009 Jan; 234(2):202-8. PubMed ID: 18992762
[TBL] [Abstract][Full Text] [Related]
34. Renal circadian clock regulates the dosing-time dependency of cisplatin-induced nephrotoxicity in mice.
Oda M; Koyanagi S; Tsurudome Y; Kanemitsu T; Matsunaga N; Ohdo S
Mol Pharmacol; 2014 May; 85(5):715-22. PubMed ID: 24567546
[TBL] [Abstract][Full Text] [Related]
35. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
36. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the protective effect of agmatine against cisplatin nephrotoxicity with 99mTc-DMSA renal scintigraphy and cystatin-C.
Salihoglu YS; Elri T; Gulle K; Can M; Aras M; Ozacmak HS; Cabuk M
Ren Fail; 2016 Oct; 38(9):1496-1502. PubMed ID: 27604130
[TBL] [Abstract][Full Text] [Related]
38. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
Nagai N; Hotta K; Yamamura H; Ogata H
Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment.
Miyamoto Y; Miyamoto M
Exp Mol Pathol; 2004 Dec; 77(3):238-45. PubMed ID: 15507242
[TBL] [Abstract][Full Text] [Related]
40. Using intracellular metabolic profiling to identify novel biomarkers of cisplatin-induced acute kidney injury in NRK-52E cells.
Kim HR; Park JH; Lee SH; Kwack SJ; Lee J; Kim S; Yoon S; Kim KB; Lee BM; Kacew S; Kim HS
J Toxicol Environ Health A; 2022 Jan; 85(1):29-42. PubMed ID: 34445936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
